Smith & Nephew SNATS Current Ratio 2010-2024 | SNN
Current and historical current ratio for Smith & Nephew SNATS (SNN) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Smith & Nephew SNATS current ratio for the three months ending June 30, 2024 was .
| Smith & Nephew SNATS Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-06-30 | $4.46B | $1.78B | 2.51 |
| 2023-12-31 | $4.03B | $2.27B | 1.78 |
| 2023-06-30 | $3.88B | $1.77B | 2.20 |
| 2022-12-31 | $3.86B | $1.72B | 2.25 |
| 2022-06-30 | $3.76B | $2.12B | 1.78 |
| 2021-12-31 | $4.42B | $2.13B | 2.08 |
| 2021-06-30 | $4.44B | $2.12B | 2.10 |
| 2020-12-31 | $4.66B | $1.69B | 2.76 |
| 2020-06-30 | $3.30B | $1.52B | 2.18 |
| 2019-12-31 | $3.22B | $1.56B | 2.06 |
| 2019-06-30 | $2.95B | $1.47B | 2.00 |
| 2018-12-31 | $3.08B | $1.47B | 2.10 |
| 2018-06-30 | $2.66B | $1.25B | 2.13 |
| 2017-12-31 | $2.73B | $1.35B | 2.03 |
| 2017-06-30 | $2.58B | $1.19B | 2.18 |
| 2016-12-31 | $2.53B | $1.35B | 1.88 |
| 2015-12-31 | $2.48B | $1.34B | 1.84 |
| 2015-06-30 | $2.43B | $1.23B | 1.99 |
| 2014-12-31 | $2.44B | $1.16B | 2.10 |
| 2014-09-30 | $2.53B | $1.23B | 2.06 |
| 2014-06-30 | $2.53B | $1.15B | 2.21 |
| 2014-03-31 | $2.39B | $1.06B | 2.25 |
| 2013-12-31 | $2.26B | $1.07B | 2.10 |
| 2013-09-30 | $2.17B | $1.03B | 2.11 |
| 2013-06-30 | $2.08B | $0.89B | 2.34 |
| 2013-03-31 | $2.07B | $0.92B | 2.26 |
| 2012-12-31 | $2.14B | $0.93B | 2.31 |
| 2012-09-30 | $2.29B | $0.91B | 2.52 |
| 2012-06-30 | $2.09B | $0.80B | 2.62 |
| 2012-03-31 | $2.32B | $1.03B | 2.26 |
| 2011-12-31 | $2.21B | $1.14B | 1.94 |
| 2011-09-30 | $2.22B | $1.29B | 1.73 |
| 2011-06-30 | $2.24B | $1.35B | 1.66 |
| 2011-03-31 | $2.21B | $0.88B | 2.51 |
| 2010-12-31 | $2.15B | $0.91B | 2.36 |
| 2010-09-30 | $2.35B | $0.86B | 2.72 |
| 2010-06-30 | $2.15B | $0.78B | 2.75 |
| 2010-03-31 | $2.09B | $0.88B | 2.38 |
| 2009-12-31 | $2.09B | $0.86B | 2.42 |
| 2009-09-30 | $2.15B | $0.91B | 2.37 |
| 2009-06-30 | $2.09B | $0.88B | 2.38 |
| 2009-03-31 | $2.00B | $1.00B | 2.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $13.465B | $5.549B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.139B | 25.33 |
| Stryker (SYK) | United States | $137.702B | 32.18 |
| Boston Scientific (BSX) | United States | $122.346B | 37.26 |
| Medtronic (MDT) | Ireland | $114.719B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.985B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.286B | 35.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
| ResMed (RMD) | United States | $35.640B | 31.38 |
| Koninklijke Philips (PHG) | Netherlands | $29.674B | 22.55 |
| Terumo (TRUMY) | Japan | $28.204B | 39.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.935B | 13.81 |
| Baxter (BAX) | United States | $19.749B | 13.39 |
| Insulet (PODD) | United States | $16.507B | 69.45 |
| Bio-Rad Laboratories (BIO) | United States | $9.256B | 30.67 |
| Demant (WILYY) | Denmark | $8.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.864B | 33.25 |
| Lantheus Holdings (LNTH) | United States | $7.251B | 17.41 |
| ICU Medical (ICUI) | United States | $4.262B | 40.67 |
| Haemonetics (HAE) | United States | $3.918B | 19.38 |
| Neogen (NEOG) | United States | $3.612B | 37.89 |
| TG Therapeutics (TGTX) | United States | $3.612B | 38.25 |
| GN Store Nord (GNNDY) | Denmark | $3.576B | 21.54 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 17.62 |
| Perrigo (PRGO) | Ireland | $3.496B | 11.05 |
| Envista Holdings (NVST) | United States | $3.310B | 17.66 |
| QuidelOrtho (QDEL) | United States | $2.970B | 18.72 |
| Agios Pharmaceuticals (AGIO) | United States | $2.734B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.220B | 37.25 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.109B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.029B | 54.07 |
| Warby Parker (WRBY) | United States | $1.620B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 9.19 |
| AdaptHealth (AHCO) | United States | $1.385B | 10.00 |
| AtriCure (ATRC) | United States | $1.384B | 0.00 |
| Owens & Minor (OMI) | United States | $1.213B | 9.36 |
| Verano Holdings (VRNOF) | United States | $1.199B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.115B | 0.00 |
| Evolus (EOLS) | United States | $1.032B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.29 |
| Phibro Animal Health (PAHC) | United States | $0.895B | 18.57 |
| National Vision Holdings (EYE) | United States | $0.852B | 27.10 |
| Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 116.58 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.483B | 14.57 |
| ZimVie (ZIMV) | United States | $0.430B | 39.97 |
| Valneva SE (VALN) | France | $0.425B | 0.00 |
| Jin Medical (ZJYL) | China | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.397B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.386B | 0.00 |
| Cerus (CERS) | United States | $0.330B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
| Aurora Cannabis (ACB) | Canada | $0.314B | 0.00 |
| Biote (BTMD) | United States | $0.295B | 13.62 |
| Viemed Healthcare (VMD) | United States | $0.281B | 30.17 |
| Zynex (ZYXI) | United States | $0.262B | 45.89 |
| Sanara MedTech (SMTI) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.233B | 15.45 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| MacroGenics (MGNX) | United States | $0.191B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.157B | 65.00 |
| FitLife Brands (FTLF) | United States | $0.152B | 20.55 |
| Brainsway (BWAY) | Israel | $0.137B | 164.20 |
| TriSalus Life Sciences (TLSI) | United States | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.117B | 0.00 |
| Veru (VERU) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.112B | 11.39 |
| Jushi Holdings (JUSHF) | United States | $0.105B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 24.00 |
| Zevia PBC (ZVIA) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.083B | 14.08 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Modular Medical (MODD) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.068B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.44 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 21.89 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |